ClinicalTrials.govpublic full text
Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder
major depressive disorder, tasimelteon, mdd, depression, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 865937
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.